SG11202100265XA - Composition for promoting uric acid excretion, composition for inhibiting urat1 and composition for lowering blood uric acid level - Google Patents
Composition for promoting uric acid excretion, composition for inhibiting urat1 and composition for lowering blood uric acid levelInfo
- Publication number
- SG11202100265XA SG11202100265XA SG11202100265XA SG11202100265XA SG11202100265XA SG 11202100265X A SG11202100265X A SG 11202100265XA SG 11202100265X A SG11202100265X A SG 11202100265XA SG 11202100265X A SG11202100265X A SG 11202100265XA SG 11202100265X A SG11202100265X A SG 11202100265XA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- uric acid
- lowering blood
- promoting
- inhibiting urat1
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title 2
- 229940116269 uric acid Drugs 0.000 title 2
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 230000029142 excretion Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pediatric Medicine (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018151541 | 2018-08-10 | ||
| PCT/JP2019/030731 WO2020031961A1 (en) | 2018-08-10 | 2019-08-05 | Composition for promoting uric acid excretion, composition for inhibiting urat1 and composition for lowering blood uric acid level |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202100265XA true SG11202100265XA (en) | 2021-02-25 |
Family
ID=69413514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202100265XA SG11202100265XA (en) | 2018-08-10 | 2019-08-05 | Composition for promoting uric acid excretion, composition for inhibiting urat1 and composition for lowering blood uric acid level |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210186924A1 (en) |
| EP (1) | EP3834627A4 (en) |
| JP (1) | JP7307073B2 (en) |
| KR (1) | KR20210042104A (en) |
| CN (1) | CN112566514A (en) |
| AU (1) | AU2019319292A1 (en) |
| SG (1) | SG11202100265XA (en) |
| TW (1) | TW202034909A (en) |
| WO (1) | WO2020031961A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7376889B2 (en) | 2019-06-28 | 2023-11-09 | 国立大学法人 東京大学 | URAT1 inhibitor and food and drink composition for URAT1 inhibition |
| CN114176212A (en) * | 2021-12-06 | 2022-03-15 | 广东省农业科学院蚕业与农产品加工研究所 | Chafing dish ingredient capable of reducing uric acid and improving immunity and preparation method thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0366669A (en) * | 1989-08-03 | 1991-03-22 | Shionogi & Co Ltd | Heterocyclic compound |
| JP3069686B2 (en) * | 1997-12-08 | 2000-07-24 | 農林水産省四国農業試験場長 | Flavanone-containing composition |
| JP2006169227A (en) | 2004-11-22 | 2006-06-29 | Asahi Breweries Ltd | Xanthine oxidase inhibitor |
| JP2006273762A (en) | 2005-03-30 | 2006-10-12 | Kikkoman Corp | Uricosuric agent |
| WO2008062740A1 (en) | 2006-11-20 | 2008-05-29 | Japan Tobacco Inc. | Nitrogenated fused ring compound and use thereof |
| DE102006062264A1 (en) | 2006-12-22 | 2008-06-26 | Joh. Barth & Sohn Gmbh & Co. Kg | Use of xanthohumol for the prevention and / or control of liver diseases |
| CN101181287A (en) | 2007-11-15 | 2008-05-21 | 南京大学 | Application of puerarin in the preparation of medicament for restraining uric acid transportor URAT1 |
| CN101181261A (en) | 2007-11-15 | 2008-05-21 | 南京大学 | Application of waxberry element in the preparation of medicament for restraining uric acid transportor URAT1 |
| JP5545692B2 (en) | 2008-09-04 | 2014-07-09 | ポッカサッポロフード＆ビバレッジ株式会社 | Xanthine oxidase inhibitor and plasma uric acid level-lowering agent |
| JP5563985B2 (en) | 2008-10-15 | 2014-07-30 | キッセイ薬品工業株式会社 | Phenylisonicotinic acid derivative and pharmaceutical use thereof |
| JPWO2011108059A1 (en) | 2010-03-01 | 2013-06-20 | 株式会社サウスプロダクト | Xanthine oxidase inhibitor |
| ES2401361B1 (en) * | 2011-06-16 | 2014-01-22 | Universidad Autónoma de Madrid | HEALTHY FUNCTIONAL DRINK OF WINE AND Hops EXTRACTS |
| CN103599123B (en) * | 2013-12-03 | 2016-03-02 | 罗观堤 | A kind of medicine for the treatment of purine metabolic disorder disease |
| JP6418456B2 (en) | 2015-02-25 | 2018-11-07 | 沖縄ハム総合食品株式会社 | Uric acid excretion promoting composition |
| JP6721905B2 (en) | 2015-09-25 | 2020-07-15 | サッポロホールディングス株式会社 | Blood uric acid level lowering agent |
| JP7062433B2 (en) | 2017-12-20 | 2022-05-06 | 株式会社ファンケル | Composition for reducing blood uric acid level containing chitosan and ampelopsin |
-
2019
- 2019-08-05 JP JP2020535758A patent/JP7307073B2/en active Active
- 2019-08-05 WO PCT/JP2019/030731 patent/WO2020031961A1/en unknown
- 2019-08-05 EP EP19846844.9A patent/EP3834627A4/en not_active Withdrawn
- 2019-08-05 US US17/265,693 patent/US20210186924A1/en active Pending
- 2019-08-05 AU AU2019319292A patent/AU2019319292A1/en not_active Abandoned
- 2019-08-05 KR KR1020217003934A patent/KR20210042104A/en unknown
- 2019-08-05 CN CN201980052828.2A patent/CN112566514A/en active Pending
- 2019-08-05 SG SG11202100265XA patent/SG11202100265XA/en unknown
- 2019-08-08 TW TW108128219A patent/TW202034909A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020031961A1 (en) | 2020-02-13 |
| US20210186924A1 (en) | 2021-06-24 |
| KR20210042104A (en) | 2021-04-16 |
| EP3834627A4 (en) | 2022-05-04 |
| TW202034909A (en) | 2020-10-01 |
| AU2019319292A1 (en) | 2021-02-04 |
| JPWO2020031961A1 (en) | 2021-08-12 |
| JP7307073B2 (en) | 2023-07-11 |
| EP3834627A1 (en) | 2021-06-16 |
| CN112566514A (en) | 2021-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288104A (en) | Heterocyclic compounds, preparation methods and uses thereof | |
| HRP20190514T1 (en) | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis | |
| ZA201800641B (en) | Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders | |
| EP3539963A4 (en) | Nitrogen-containing heterocyclic compound, preparation method, intermediate, pharmaceutical composition and use | |
| AP2012006191A0 (en) | Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same. | |
| EP2432774A4 (en) | Compounds, compositions and methods for modulating uric acid levels | |
| AU2015275507A8 (en) | Cyclic dipeptide-containing composition | |
| EA201890694A1 (en) | GROUP OF COMPOUNDS USING FOR THE TREATMENT OR PREVENTION OF HYPERURICEMIA OR Gout | |
| IL281740A (en) | Compositions for reducing serum uric acid | |
| DK2467364T3 (en) | Nitrogen-containing compounds and pharmaceutical compositions for the treatment of atrial fibrillation. | |
| DK3481819T3 (en) | COMPOUNDS AND USE THEREOF FOR REDUCING URIC ACID LEVELS | |
| SG11202100265XA (en) | Composition for promoting uric acid excretion, composition for inhibiting urat1 and composition for lowering blood uric acid level | |
| EP3890722A4 (en) | Methods for treating or preventing gout or hyperuricemia | |
| PL3632904T3 (en) | Urat1 inhibitors for promoting uric acid excretion | |
| EP3247704A4 (en) | Bifunctional compounds and use for reducing uric acid levels | |
| EP3162803A4 (en) | New compound for inhibiting binding between dx2 protein and p14/arf protein, and pharmaceutical composition for treating or preventing cancer disease containing same as effective ingredient | |
| WO2011080651A3 (en) | Polymorphic forms of febuxostat | |
| SG11202001327RA (en) | Composition for reducing serum uric acid level | |
| EP3443849A4 (en) | Food composition or combination for lowering blood glucose level or reducing gi value | |
| EP3827837A4 (en) | Composition for preventing or treating immune-related diseases | |
| MX2016015577A (en) | Theobromine or its derivatives for the treatment or prevention of renal lithiasis. | |
| EP4052704A4 (en) | Composition for sleep improvement comprising ergothioneine or salt thereof | |
| GB2592803B (en) | Compounds for use in preventing or treating athlete overtraining | |
| EP3981423A4 (en) | Composition for preventing or treating uric acid-related disease | |
| GB2589341B (en) | Composition and method for uric acid removal |